Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (291-300 of 325) with videos related to

Pageof 33
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 3, 2021
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemiaMichelle J Cox, Fabrice Lucien, Reona Sakemura, et al.
Leukemia|July 21, 2021
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African AmericansGeffen Kleinstern, J Brice Weinberg, Sameer A Parikh, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2018
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaJacqueline C Barrientos, Susan O'Brien, Jennifer R Brown, et al.
Blood|December 7, 2010
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLLSusan L Slager, Kari G Rabe, Sara J Achenbach, et al.
Frontiers in Oncology|July 29, 2022
Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic LeukemiaMatthew Kaufman, Xiao-Jie Yan, Wentian Li, et al.
Mayo Clinic Proceedings|June 5, 2026
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026Sameer A Parikh, Paul J Hampel, Lindsey E Roeker, et al.
Blood Cancer Discovery|February 19, 2021
Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and TherapyHelene Kretzmer, Anat Biran, Noelia Purroy, et al.
Blood Cancer Journal|January 7, 2026
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experienceDomitilla Baccon, Suheil Albert Atallah-Yunes, Paul J Hampel, et al.
Journal of Hematology & Oncology|January 16, 2021
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Bonnie Harrington, et al.
Mbio|April 11, 2024
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19Juan G Ripoll, Sidna M Tulledge-Scheitel, Anthony A Stephenson, et al.
Pageof 33

Showing results (291-300 of 325) with videos related to

Sort By:
Pageof 33
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 3, 2021
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemiaMichelle J Cox, Fabrice Lucien, Reona Sakemura, et al.
Leukemia|July 21, 2021
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African AmericansGeffen Kleinstern, J Brice Weinberg, Sameer A Parikh, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2018
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaJacqueline C Barrientos, Susan O'Brien, Jennifer R Brown, et al.
Blood|December 7, 2010
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLLSusan L Slager, Kari G Rabe, Sara J Achenbach, et al.
Frontiers in Oncology|July 29, 2022
Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic LeukemiaMatthew Kaufman, Xiao-Jie Yan, Wentian Li, et al.
Mayo Clinic Proceedings|June 5, 2026
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026Sameer A Parikh, Paul J Hampel, Lindsey E Roeker, et al.
Blood Cancer Discovery|February 19, 2021
Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and TherapyHelene Kretzmer, Anat Biran, Noelia Purroy, et al.
Blood Cancer Journal|January 7, 2026
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experienceDomitilla Baccon, Suheil Albert Atallah-Yunes, Paul J Hampel, et al.
Journal of Hematology & Oncology|January 16, 2021
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Bonnie Harrington, et al.
Mbio|April 11, 2024
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19Juan G Ripoll, Sidna M Tulledge-Scheitel, Anthony A Stephenson, et al.
Pageof 33